Bottom line
Is KNGAX a good fund? The bottom line
KNGAX is the Class A share class of Vest S&P 500 Dividend Aristocrats Target Income Fund, a managed core / intermediate bond mutual fund from World.
It charges 1.2% — about $120 a year on every $10,000 invested, more expensive than 80% of core / intermediate bond funds we track.
It returned −0.3% over one year, +5.1% a year over five years (as of Dec 31, 2025, per its prospectus).
With $48.5 million in net assets and 99 holdings, its largest position is Automatic Data (1.8%) and the top 10 make up 16.9% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 83% of category peers
What to watch
- Expensive for its category (1.2%)
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
- Small fund ($48.5 million) — small funds are likelier to close
- High turnover (423% a year) can mean more taxable distributions
Updated Nov 19, 2026
What KNGAX invests in
The Vest S&P 500 Dividend Aristocrats Target Income Fund (the Aristocrats Fund or, solely for this Fund Summary, the Fund) seeks to track the price and yield performance, before fees and expenses, of the Cboe S&P 500 Dividend Aristocrats Target Income Index (the Cboe Aristocrats Index).
The Fund employs an investment approach designed to track the performance of the Cboe Aristocrats Index before fees and expenses. The Cboe Aristocrats Index is designed with the primary goal of generating an annualized level of income that is approximately 10% over the annual dividend yield of the S&P 500 Index and a secondary goal of generating limited capital appreciation based on the returns of the equity components of the S&P 500 Dividend Aristocrats Index. About the Indexs Strategy The Cboe Aristocrats Index, constructed and maintained by the Cboe Global Markets Inc. (Index Calculation Agent and/or Cboe), is designed with the primary goal of generating an annualized level of income that is approximately 10% over the annual dividend yield of the S&P 500 Index and a secondary goal of generating limited capital appreciation based on the returns of the equity components of the S&P 500…
From the fund's prospectus (filed Feb 27, 2026).
KNGAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| KNGAX | −0.3% | +5.1% | — |
| Core / Intermediate Bond median | +7.2% | +1.4% | +3.0% |
Source: Fund prospectus, as of Dec 31, 2025
What KNGAX costs
On a $10,000 investment, KNGAX's 1.2% expense ratio costs about $120 a year. The prospectus estimates $2,541 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.
KNGAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Automatic Data | 1.80% |
| 2 | Jm Smucker Co | 1.71% |
| 3 | Franklin Res Inc | 1.71% |
| 4 | West Pharmaceut | 1.70% |
| 5 | Stanley Black & | 1.70% |
| 6 | Nucor Corp | 1.70% |
| 7 | Abbvie Inc | 1.68% |
| 8 | Default | 1.62% |
| 9 | General Dynamics | 1.62% |
| 10 | Default | 1.62% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 16.9% of the fund. See all top 25 holdings and asset mix →